Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension

Journal of Hepatology

Volumn 36, Issue 5, 2002, Pages 600-606

  Yang, Ying Ying ^a   Lin, Han Chieh ^a   Huang, Yi Tsau ^a   Lee, Tzung Yen ^a   Hou, Ming Chih ^a   Lee, Fa Yauh ^a   Liu, Ren Shyan ^b   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin; Cirrhosis; Hemodynamics; Losartan; Nitric oxide; Portal hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEMATOCRIT; HEMODYNAMICS; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; COMMON BILE DUCT; ENZYME INHIBITORS; HEMATOCRIT; HYPERTENSION, PORTAL; LIGATION; LIVER CIRCULATION; LIVER CIRRHOSIS; LOSARTAN; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; PLASMA VOLUME; RATS; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 0036258020     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00037-5     Document Type: Article

References (44)

1. Hyperdynamic circulation in a portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension
2. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites
3. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats
4. Vasodilatation and sodium retention in prehepatic portal hypertension
5. Upregulation of the endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats
6. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites
7. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
8. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition
9. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
10. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
11. G-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats
12. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
13. Increased sympathetic outflow in cirrhosis and ascites: Direct evidence from intraneural recordings
14. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relations to hemodynamics
15. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis
16. Effect of angiotensin-II blockade one systemic and hepatic hemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites
17. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis
18. Haemodynamic, renal sodium handling and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis
19. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
20. Randomized comparison of the long-term losartan versus propranolol in lowering portal pressure in cirrhosis
21. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat
22. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension
23. Adaptive vasodilatory response after octreotide treatment
24. Nitric oxide production by monocyte in alcoholic liver disease
25. Electrochemical detection of catecholamines in urine and plasma after separation with HPLO
26. Vasodilatation and plasma volume in portal hypertension
27. Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats
28. Effect of blockade of angiotensin II on blood pressure renin and aldosterone in cirrhosis
29. Elevated sympathetic nerve activity in patients with accelerated essential hypertension
30. Renal dysfunction in cirrhosis
31. + restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension
32. Angiotensin II induces contraction and proliferation of human hepatic stellate cells
33. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension
34. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery
35. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase
36. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells
37. AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries
38. Flow-induced release of endothelium-derived relaxing factor
39. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats
40. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension
41. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats
42. Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats
43. Decreased pressor reactivity to angiotensin II in cirrhotic rats: Evidence for a post-receptor defect in angiotensin action
44. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide